alexa Effect of Sevoflurane Preconditioning on Inflammatory Cytokines and Oxygen Radicals During Single Lung Ventilation in Patients with Lung Cancer | Open Access Journals
ISSN: 1948-5956
Journal of Cancer Science & Therapy
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Effect of Sevoflurane Preconditioning on Inflammatory Cytokines and Oxygen Radicals During Single Lung Ventilation in Patients with Lung Cancer

Hao Zhang, Yilu Zhou, Yinglin Wang and Qingxiu Wang*

Department of Anaesthesiology, Shanghai East Hospital, Tongji University School of Medicine, China

*Corresponding Author:
Wang Q
Department of Anaesthesiology, Shanghai East Hospital
Tongji University School of Medicine, 150 Jimo Road
Shanghai 200120, China
Tel: + 862161569776

Received date: October 05, 2016; Accepted date: November 25, 2016; Published date: November 28, 2016

Citation: Zhang H, Zhou Y, Wang Y, Wang Q (2016) Effect of Sevoflurane Preconditioning on Inflammatory Cytokines and Oxygen Radicals During Single Lung Ventilation in Patients with Lung Cancer. J Cancer Sci Ther 8: 274-276. doi: 10.4172/1948-5956.1000426

Copyright: © 2016 Zhang H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Cancer Science & Therapy


Objective: To observe the effect of sevoflurane preconditioning on inflammatory cytokines and oxygen radicals during single lung ventilation (SLV) in patients with lung cancer and to discuss the mechanism of sevoflurane induced lung protection.

Methods: Thirty patients, ASA I or II, with non-small-cell lung cancer underwent pulmonary surgeries were randomized into two groups: sevoflurane preconditioning group (group S, n=15) and control group (group C, n=15). After general anaesthesia induction. A double-lumen tube was placed and the position was checked by a fibre optic bronchoscope. During the mechanical ventilation, patients in group S, received sevoflurane at 1.0 minimum alveolar concentration (MAC) for 30 min as a preconditioning and then replaced by oxygen for a complete rapid gas exchange to reduce the sevoflurane inhalation concentration to 0 before SLV. While in group C, only intravenous anaesthetic agents, fentanyl and propofol, were administrated before SLV. Blood concentrations of TNF-α, IL-6, IL-8, SOD and MDA were measured at Post-induction of anaesthesia (T1), 30 min after SLV in the lateral position (T2), 60 min after SLV in the lateral position (T3), and at the end of the operation (T4).

Results: When compared with Tl, the concentrations of TNF-α, IL-6 and MDA in both groups and the IL-8 in group S were significantly increased at T2-T4 (P<0.05), while the expression of SOD in two groups were decreased significantly(P<0.05). The concentrations of TNF-α, IL-6, IL-8 and MDA in group S were decreased significantly at T2-T4 (P<0.05 or P<0.01) when compared with those in group C. The activity of SOD in group S was significantly increased at T3 and T4 (P<0.05).

Conclusion: Sevoflurane preconditioning may moderate the release of inflammatory cytokines to inhibit the inflammatory reaction and may reduce the lipid peroxidation by inhibiting the generation of oxygen free radical. It may protect the lung from the injury during SLV.


Sevoflurane preconditioning; Cytokine; Oxygen free radical; Single lung ventilation


Single lung ventilation (SLV) is a common way of ventilation, with its application in lung cancer surgery, lung injury caused by SLV has raised widely attention. Sevoflurane is a type of inhalation anaesthetics medicine, it is features for rapid awakening and easy to control, has been widely used in recent years. Studies have shown that sevoflurane pre-treatment could have effect of lung protective, think that inhaled sevoflurane pre-treatment can reduce the lungs injury, protect lung function in patients with lung cancer during SLV. Also, Oxygen free radicals and inflammatory cytokines plays an important role in the lung injury. This study aim to observe the sevoflurane preconditioning in patients with lung cancer underwent SLV and the influence of inflammatory cytokines and oxygen free radicals, investigate the lung protection mechanism of sevoflurane.

Materials and Methods

General information

We enrolled 30 patients with non-small cell lung cancer from March 2015 to March 2016. male 15 cases, 15 cases were female, aged 40 to 65, weight 50 kg to 75 kg, ASA I or II level. Exclusion criteria were as follows: cervical spine disease that restricted head extension; oropharyngeal disease; presence of loose or vulnerable teeth. Preoperative patients accepted chemotherapy two period, all patients were given medicine to prevent nausea and vomiting. Patients were randomly allocated by an independent anaesthesiologist (Lihua Wang) into either sevoflurane preconditioning group (group S) or control group (group C).

Anaesthesia methods

Each patient was laid on the operating table, non-invasive blood pressure, three-lead ECG, and oxygen saturation were monitored. Anaesthesia was induced with: intravenous midazolam 0.04 mg/kg, fentanyl l.4 μg/kg, TCI propofol 3.5 μg/ml and atracurium 0.2 mg/kg. Patients were intubated with a double-lumen tube with the help of fibre optic bronchoscope. Underwent mechanical ventilation, set VT 6 ml/ kg ~ 8 ml/kg, RR 10/min ~ 14/min, PETCO2 35 mmHg to 45 mmHg. In group S, after successful intubation, inhalation sevoflurane for 30 min before SLV, after the completion of sevoflurane pre-treatment, maintain at 1.0 minimum alveolar concentration (MAC) effectively, stop using sevoflurane pre-treatment. Then using 100% concentration oxygen exchange sevoflurane, before make SLV, sevoflurane inhalation concentration to 0. In group C Propofol 3.5 μg/ml and fentanyl 4 μg/ kg intravenous infusion maintenance of anaesthesia to SLV start. Both groups maintain the anaesthesia with TCI propofol 3.5 μg/ml, fentany l.4 μg/kg and atracurium 0.2 mg/kg to maintain muscle relaxant. Maintain the BIS between 40~60, if necessary, to give vasoactive drugs.

Observing indexes

At time of Post-induction of anaesthesia (T1), SLV after 30 min in the lateral position (T2), SLV after 60 min in the lateral position (T3), and at the end of the operation (T4), From the right internal jugular vein to collect the static Vein blood, serum after centrifugation, cryopreservation unified detection. Determination of blood tumour necrosis factor (TNF-α), IL - 6, IL-8 and malondialdehyde (MDA) concentration and superoxide dismutase (SOD) activity, operating in accordance with the kit instructions. Records of patients who infusion, blood loss, the first second forced expiratory volume (FEV1), operation time and SLV time. Using SPSS 18.0 statistical analysis software for data processing, using t test, group is adopted from repetitive measure analysis of variance.


There was no statistically significant difference compared two groups of patients with general data (Table 1). Compared with the T1, at time T2~T4, two groups of concentration of TNF-α and concentration of IL-6 significantly increased. At time T3 and T4, two groups of concentration of IL-8 concentration increased significantly (P<0.05). Compared with group C, at timeT2~T4, in group S, concentration of TNF-α, IL-6 and IL-8 significantly decreased (P<0.05 or P<0.01) (Table 2).

Group Number Male/Female Age (Year) Weight (kg)
S 15 6/9 55.2 ± 10.4 70.7 ± 10.8
C 15 9/6 56.7 ± 12.6 67.6 ± 9.4

Table 1: General conditions.

Index Group Number T1 T2 T3 T4
TNF-α S 15 4.9 ± 1.4 10.6 ± 1.6ac 22.2 ± 4.0ac 31.6 ± 5.7ac
C 15 5.0 ± 1.3 16.5 ± 3.1a 40.6 ± 7.8a 45.8 ± 8.3a
IL-6 S 15 11.0 ± 1.5 16.6 ± 4.1ac 31.3 ± 8.6ab 40.8 ± 6.6ac
C 15 10.6 ± 1.3 26.5 ± 9.8a 38.5 ± 10.4a 51.0 ± 6.1a
IL-8 S 15 9.1 ± 1.1 10.3 ± 2.4b 13.8 ± 2.6ab 21.3 ± 4.7ab
C 15 8.9 ± 1.0 12.1 ± 1.9a 14.3 ± 3.4a 26.6 ± 3.2a
Compared with the T1,aP<0.05; Compared with Group C, bP<0.05, cP<0.01

Table 2: The comparison of two groups of patients with different time point TNF-α,IL-6,IL-8 concentration.

Compared with the time T1, at time T2~T4, two groups of SOD activity decreased obviously (P<0.05), MDA concentration increased significantly (P<0.05). Compared with group C, At timeT3, T4. group S SOD activity significantly increased (P<0.05), MDA concentration significantly decreased (P<0.05 or P<0.01) (Table 3). Two groups of patients with surgical time, SLV, FEV1, and transfusion volume and the bleeding comparative differences had no statistical significance.

Index Group Number T1 T2 T3 T4
SOD S 15 100.2 ± 8.7 94.9 ± 9.8a 90.1 ± 10.6ac 84.1 ± 10.7ab
C 15 102.9 ± 11.5 92.9 ± 10.2a 86.2 ± 9.4a 78.5 ± 11.0a
MDA S 15 4.3 ± 0.8 5.2 ± 0.8a 5.8 ± 1.2ab 6.7 ± 1.0ab
C 15 4.2 ± 0.7 5.0 ± 0.9a 6.4 ± 0.8a 8.2 ± 1.2a
Compared with the T1, aP<0.05; Compared with Group C, bP<0.05, cP<0.01

Table 3: Two groups of patients with the comparison of different time points of SOD activity and MDA concentration.


TNF-α as early inflammatory factors may induce other inflammatory mediators, including the release of IL-6, IL-8, start the inflammatory cascade reaction, induction of neutrophil degranulation and the endothelial cell adhesion, IL-6 is strongest in former inflammatory cytokines, inflammatory mediators related to the strict degree of tissue damage and duration, [1] reflect the operation stress caused by the severity of the inflammatory response, IL-8 is acknowledged as the inflammatory reaction in the specific cytokines lead to lung tissue damage, the white blood cells have strong chemotaxis. In this study, maintain PETCO2 anaesthesia in the normal range, by the BIS monitoring anaesthesia depth at the same level. per the results of this study, two groups of patients with TNF-α, IL-6, concentration of IL-8 with SLV increased with the extension of time, the instructions SLV make TNF-α, IL-6, IL-8 levels and cause lung damage. Studies have reported that sevoflurane by lowering the serum concentration of TNF-α and IL-8. SLV lung injury caused by protection, inhibiting the release of TNF-α sevoflurane pre-treatment, inhibit sexual response, pneumonia after CPB in early lung injury after CPB not only has certain protective effect [2], but also to IL-8 and inflammatory factor has inhibitory effect., according to the results of this study compared with group C, group S TNF-α after SLV, IL-6 and IL-8 concentration significantly decreased, show that sevoflurane preconditioning can inhibit the expression of inflammatory cytokines or release, so as to reduce its damage of endothelial cells and the surrounding tissue, reducing the level of inflammatory response in lung injury after SLV has certain protective effect, but its mechanism still need further study.

SOD is one of the mediated endogenous antioxidant mechanism, is a major enzyme the body of free radicals [3], SOD activity and indirectly reflect the organization’s ability to remove free radicals, MDA is a decomposition product of lipid peroxidation levels of MDA in the blood change reflects the change of oxygen free radicals in the organization, by measuring the MDA and SOD can reflect the occurrence of oxygen free radicals. In this study, 30 min after SLV is two groups of SOD activity gradually reduced, MDA concentration increased significantly, explain SLV is caused by oxygen free radicals. Compared with group C, 60 min after SLV, never put off till tomorrow what you can obviously increase the SOD activity, and MDA concentration is reduced, that sevoflurane pre-treatment can reduce the generation of oxygen free radicals. And 30 min after SLV [4], group S MDA concentration higher than that of group C, the role of sevoflurane metabolism in the body could be produced in the process of oxidation to alkyl peroxide further to produce oxygen free radical, antioxidant mechanism of jump-starting the body, inhibition of oxygen free radicals generated in the end [5].

To sum up, sevoflurane pre-treatment process by inhibiting the expression of inflammatory cytokines or release, reduce the production of oxygen free radicals, eventually produce protective effect in the process of SLV lung injury. Sevoflurane inhalation in advance for the use of optimal concentration and its protective mechanism remains to be step in the research.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 520
  • [From(publication date):
    November-2016 - Apr 25, 2017]
  • Breakdown by view type
  • HTML page views : 485
  • PDF downloads :35

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version